New real world data analyses determine yet again, that use of GLP-1 receptor agonists was not associated with an increased risk of suicidality compared with the use of DPP-4 inhibitors or SGLT-2 inhibitors in patients with type 2 #diabetes https://t.co/rzhotLMQsU @bmj_latest
Concerns have been raised about a possible link between GLP-1 RAs and suicidality. Our latest study published in the @bmj_latest provides reassuring findings.
Great work by my doctoral student Samantha Shapiro and team!
https://t.co/tP4kFtqoja
🚨Fresh off the press in @DrugSafetyJ!
We observed a 46% increased risk of gallbladder and bile duct disease associated with use of DPP-4 inhibitors. Give it a read at https://t.co/KcyLolgS9g
@profLAzoulay#rxepi 💊
Excited to share my first paper with @profLAzoulay on the association between SGLT-2 inhibitor use and the risk of lung cancer. Check out my first official foray into cancer pharmacoepidemiology in @BritJClinPharm! 💊🧫 #rxepi
https://t.co/Be3NFLgcwK
Had the pleasure of presenting my research on DPP-4 inhibitor use and the risk of biliary tract disease today at #ICPE23. A big thank you to all who attended, and thanks to @IntPharmacoEpi and @robertwplatt for a great conference so far!
"Diseases typically classified as 'women’s health,' such as endometriosis, are particularly poorly funded relative to their associated burdens. Yet, the inequity affects a much broader range of female dominated conditions..." @LiisaGalea@DrRulanParekh
https://t.co/IJ1CUMIGGn
It’s been an exciting two months between receiving a doctoral award from @CIHR_IRSC, defending my thesis protocol, getting an oral presentation at @IntPharmacoEpi 2023, and publishing a new manuscript. So grateful for all my collaborators, and looking forward to the work to come!
Circumcision may be a viable preventive strategy for HPV infections, especially in regions with a high burden of HPV-associated cancers and where the HPV vaccine is not commercially available or has low uptake. (8/8)
🧵Pleased to share my final publication from my MSc, now published in @CMIJournal: a systematic review and meta-analysis of the association between male circumcision and HPV infections in males and their female sexual partners. @McGill_DCE@ESCMID (1/)
https://t.co/ihTTtjUXCE
Future studies on the topic should be aware of the impact of sampling site on accurate infection detection in males. More studies of HPV infection risk among the female sexual partners of circumcised vs. uncircumcised males are warranted. (7/)
(1/4) Today, Health Canada authorized a second vaccine booster targeting Omicron subvariants. This is an updated version of the Pfizer-BioNTech Comirnaty #CovidVaccine, and is authorized for use as a booster dose in individuals 12 years of age and older. https://t.co/BmmuKAFDoI